These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. Wang DW; Yazawa K; George AL; Bennett PB Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13200-5. PubMed ID: 8917568 [TBL] [Abstract][Full Text] [Related]
23. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation. Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377 [TBL] [Abstract][Full Text] [Related]
24. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. Antzelevitch C; Sun ZQ; Zhang ZQ; Yan GX J Am Coll Cardiol; 1996 Dec; 28(7):1836-48. PubMed ID: 8962574 [TBL] [Abstract][Full Text] [Related]
25. In utero onset of long QT syndrome with atrioventricular block and spontaneous or lidocaine-induced ventricular tachycardia: compound effects of hERG pore region mutation and SCN5A N-terminus variant. Lin MT; Wu MH; Chang CC; Chiu SN; Thériault O; Huang H; Christé G; Ficker E; Chahine M Heart Rhythm; 2008 Nov; 5(11):1567-74. PubMed ID: 18848812 [TBL] [Abstract][Full Text] [Related]
26. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel. Wei J; Wang DW; Alings M; Fish F; Wathen M; Roden DM; George AL Circulation; 1999 Jun; 99(24):3165-71. PubMed ID: 10377081 [TBL] [Abstract][Full Text] [Related]
27. In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes. Vecchietti S; Grandi E; Severi S; Rivolta I; Napolitano C; Priori SG; Cavalcanti S Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H56-65. PubMed ID: 16980337 [TBL] [Abstract][Full Text] [Related]
28. Arrhythmogenic mechanism of an LQT-3 mutation of the human heart Na(+) channel alpha-subunit: A computational analysis. Wehrens XH; Abriel H; Cabo C; Benhorin J; Kass RS Circulation; 2000 Aug; 102(5):584-90. PubMed ID: 10920073 [TBL] [Abstract][Full Text] [Related]
29. Electrical heterogeneity within the ventricular wall. Antzelevitch C; Fish J Basic Res Cardiol; 2001 Nov; 96(6):517-27. PubMed ID: 11770069 [TBL] [Abstract][Full Text] [Related]
30. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome. Kambouris NG; Nuss HB; Johns DC; Marbán E; Tomaselli GF; Balser JR J Clin Invest; 2000 Apr; 105(8):1133-40. PubMed ID: 10772658 [TBL] [Abstract][Full Text] [Related]
31. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts modelling the Brugada syndrome. Stokoe KS; Balasubramaniam R; Goddard CA; Colledge WH; Grace AA; Huang CL J Physiol; 2007 May; 581(Pt 1):255-75. PubMed ID: 17303635 [TBL] [Abstract][Full Text] [Related]
33. The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology. Priori SG; Cantù F; Schwartz PJ Schweiz Med Wochenschr; 1996 Oct; 126(41):1727-31. PubMed ID: 8893413 [TBL] [Abstract][Full Text] [Related]
34. SCN5A channelopathies--an update on mutations and mechanisms. Zimmer T; Surber R Prog Biophys Mol Biol; 2008; 98(2-3):120-36. PubMed ID: 19027780 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms and management of congenital and acquired long QT syndromes. Lazzara R Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():51-5. PubMed ID: 8734164 [TBL] [Abstract][Full Text] [Related]
36. Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels. Huang H; Priori SG; Napolitano C; O'Leary ME; Chahine M Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H288-99. PubMed ID: 21076026 [TBL] [Abstract][Full Text] [Related]
37. Modeling incomplete penetrance in long QT syndrome type 3 through ion channel heterogeneity: an in silico population study. Miller JA; Moise N; Weinberg SH Am J Physiol Heart Circ Physiol; 2023 Feb; 324(2):H179-H197. PubMed ID: 36487185 [TBL] [Abstract][Full Text] [Related]
38. Pharmacological separation of early afterdepolarizations from arrhythmogenic substrate in DeltaKPQ Scn5a murine hearts modelling human long QT 3 syndrome. Thomas G; Killeen MJ; Grace AA; Huang CL Acta Physiol (Oxf); 2008 Apr; 192(4):505-17. PubMed ID: 17973950 [TBL] [Abstract][Full Text] [Related]
39. Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine. Sicouri S; Timothy KW; Zygmunt AC; Glass A; Goodrow RJ; Belardinelli L; Antzelevitch C Heart Rhythm; 2007 May; 4(5):638-47. PubMed ID: 17467634 [TBL] [Abstract][Full Text] [Related]